Medicare Enrolled
Dr. Marwan Zoghbi, MD
Family Medicine · Visalia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Zoghbi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zoghbi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Zoghbi
Dr. Marwan Zoghbi is a family medicine specialist in Visalia, CA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Zoghbi performed 1,869 Medicare services across 1,155 unique beneficiaries.
Between the years covered by Open Payments, Dr. Zoghbi received a total of $6,186 from 39 pharmaceutical and/or device companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Zoghbi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 11% volume in CA
$6,186 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,869
Medicare services
Top 11% in CA for family medicine
1,155
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
670 | $91 | $175 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $56 | $120 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
216 | $62 | $115 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
174 | $54 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
150 | $131 | $399 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
72 | $138 | $254 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
59 | $95 | $180 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
41 | $157 | $282 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $11 | $50 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
30 | $65 | $122 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $137 | $250 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
25 | $90 | $123 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $98 | $125 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $125 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,186
Total received (2018-2024)
Avg $884/year across 7 years
Top 7% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
349
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,073 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$113 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,063
2023
$1,191
2022
$1,093
2021
$1,335
2020
$707
2019
$417
2018
$380
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$264
Phathom Pharmaceuticals, Inc.
$188
Novo Nordisk Inc
$93
ABBVIE INC.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
GlaxoSmithKline, LLC.
$56
Otsuka Pharmaceutical Development & Commercialization, Inc.
$46
Lilly USA, LLC
$45
Bayer Healthcare Pharmaceuticals Inc.
$45
PFIZER INC.
$44
Amgen Inc.
$40
Otsuka America Pharmaceutical, Inc.
$29
Abbott Laboratories
$27
Seqirus USA Inc
$19
Daiichi Sankyo Inc.
$18
Dexcom, Inc.
$17
Top 3 companies account for 51.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$973
Lilly USA, LLC
$850
GlaxoSmithKline, LLC.
$558
AstraZeneca Pharmaceuticals LP
$524
Boehringer Ingelheim Pharmaceuticals, Inc.
$501
Janssen Pharmaceuticals, Inc
$388
AbbVie Inc.
$277
PFIZER INC.
$249
Amgen Inc.
$215
Phathom Pharmaceuticals, Inc.
$188
ABBVIE INC.
$135
Edwards Lifesciences Corporation
$119
Novartis Pharmaceuticals Corporation
$114
Astellas Pharma US Inc
$113
Bayer Healthcare Pharmaceuticals Inc.
$102
Bayer HealthCare Pharmaceuticals Inc.
$82
Abbott Laboratories
$78
Allergan Inc.
$74
Ironwood Pharmaceuticals, Inc
$69
Otsuka America Pharmaceutical, Inc.
$67
Allergan, Inc.
$66
Otsuka Pharmaceutical Development & Commercialization, Inc.
$46
Dexcom, Inc.
$39
Hologic, LLC
$39
Seqirus USA Inc
$35
Merck Sharp & Dohme Corporation
$31
Biohaven Pharmaceuticals, Inc.
$30
IDORSIA PHARMACEUTICALS US INC
$30
E.R. Squibb & Sons, L.L.C.
$24
Philips Electronics North America Corporation
$24
ITI, Inc.
$21
Biohaven Pharmaceutical Holding Company Ltd.
$19
Daiichi Sankyo Inc.
$18
Medtronic Vascular, Inc.
$16
DEXCOM, INC.
$16
Mylan Specialty L.P.
$15
Esperion Therapeutics, Inc.
$15
Organon LLC
$14
MannKind Corporation
$13
Top 3 companies account for 38.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APTIMA · Aimovig · Aptima HPV · BAQSIMI · BREZTRI · CAPLYTA · CHANTIX · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad Quadrivalent · Flucelvax · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYUMJEV · Linzess · MOUNJARO · NEXLETOL · NEXPLANON · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Respiratoriy Care Undiv · Rybelsus · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYNTHROID · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · UBRELVY · VIIBRYD · VOQUEZNA · VRAYLAR · VenaSeal · Veozah · Wegovy · XARELTO · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for family medicine in CA.
Geographic Context
Family medicine physicians within 10 mi
211
Per 100K population
44.3
County median income
$69,489
Nearest hospital
KAWEAH HEALTH MEDICAL CENTER
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Zoghbi is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement in the top 7% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Zoghbi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Zoghbi performed 670 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zoghbi receive payments from pharmaceutical companies?
Yes. Dr. Zoghbi received a total of $6,186 from 39 companies across 349 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zoghbi's costs compare to other family medicine physicians in Visalia?
Dr. Zoghbi's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zoghbi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Visalia
Browse family medicine physicians in Visalia ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in CA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in CA
Which CA family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology